Avelas Biosciences Secures $20,000,000 Series C Funding Round
- Feed Type
- Link
http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=7d973ed4-5186-47f5-ae4a-2889169a248a - Date
8/19/2016 - Company Name
Avelas Biosciences - Mailing Address
11099 North Torrey Pines Road La Jolla, CA 92037 USA - Company Description
Avelas Biosciences develops real-time luminous maps for oncologic surgeons to refer while in surgery. - Website
http://www.avelasbio.com - Transaction Type
Venture Equity - Transaction Amount
$20,000,000 - Transaction Round
Series C - Proceeds Purposes
Avelas Biosciences plans to use the proceeds to advance AVB-620, a “cancer illuminator,” into late-stage clinical trials, to develop new targeted therapeutics for cancer and for general corporate purposes. - M&A Terms
- Venture Investor
Pharmstandard - Venture Investor
Alexandria Venture Investments - Venture Investor
Avalon Ventures - Venture Investor
WuXi PharmaTech - Venture Investor
Undisclosed
